Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Theravance Biopharma (TBPH) has a market cap of $0.46 billion USD. According to our data, Theravance Biopharma is ranked No.6223 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.46 B |
-0.53%
|
| Dec 31, 2024 | $0.46 B |
-16.28%
|
| Dec 29, 2023 | $0.55 B |
0.18%
|
| Dec 30, 2022 | $0.55 B |
1.54%
|
| Dec 31, 2021 | $0.54 B |
-37.82%
|
| Dec 31, 2020 | $0.87 B |
-31.36%
|
| Dec 31, 2019 | $1.27 B |
1.17%
|
| Dec 31, 2018 | $1.26 B |
-8.25%
|
| Dec 29, 2017 | $1.37 B |
-12.52%
|
| Dec 30, 2016 | $1.57 B |
94.51%
|
| Dec 31, 2015 | $0.81 B |
9.85%
|
| Dec 31, 2014 | $0.73 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
 Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
 Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
 Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
 Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
| Market Cap | = | TBPH Stock Price | * | TBPH Shares Outstanding |
| = | $9.36 | * | 49.17 M | |
| = | $0.46 B |